Facebook
Britain's News Portal
Around The Clock
BREAKING
Loading latest headlines…

MHRA Warns Against Dangerous Weight Loss Shortcuts Amid Rising Demand

The MHRA is cautioning the public against unsafe weight loss methods, including illicitly sold GLP-1 medicines and dangerous diet changes. They highlight the risks of fake medications and urge adherence to medical advice for healthy slimming.

  • Only use prescribed GLP-1 medicines as directed by a healthcare professional; avoid increasing doses.
  • Do not purchase weight-loss medicines from unregulated websites or social media sellers due to risks of fakes and toxic contamination.
  • Always check medication instructions before making dietary changes, as some foods can interact negatively with drugs.

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a stark warning against dangerous weight loss shortcuts, as the demand for quick-fix slimming solutions, including prescription medicines, continues to surge. With illegal advertising prevalent on social media, the agency is urging the public to prioritise health and safety over rapid results, highlighting the serious risks associated with unverified products and unadvised dietary changes.

A key concern for the MHRA is the misuse and illicit sale of GLP-1 weight-loss medicines, such as Semaglutide (Wegovy), Tirzepatide (Mounjaro), and Liraglutide (Saxenda). These powerful drugs, which are only authorised for individuals with a Body Mass Index (BMI) of 27 or more, must be taken strictly as prescribed by a healthcare professional. Overdosing or obtaining these medicines from unregulated online sources can lead to severe health complications. The MHRA specifically cautioned against the unapproved drug Retatrutide, which is being illegally sold in the UK without any safety, quality, or effectiveness testing.

Andy Morling, Head of the MHRA's Criminal Enforcement Unit, emphasised the profit-driven motives of rogue sellers, stating that their products could be contaminated with bacteria and other harmful substances. He advised consumers to be sceptical of deals that appear too good to be true and to verify that any online pharmacy is registered with the General Pharmaceutical Council. The MHRA's message is clear: if a GLP-1 medicine is offered without the need for a prescription, it should be avoided.

Beyond medication, the MHRA also highlighted the importance of dietary awareness. They reminded individuals to always consult patient information leaflets before altering their diet, as certain foods can compromise the effectiveness of medications or increase the risk of side effects. For example, individuals taking Simvastatin for cholesterol management should avoid grapefruit, while Metformin and Naproxen, commonly used for diabetes and pain respectively, require consumption with or after food to prevent stomach upset.

Alison Cave, the MHRA’s Chief Safety Officer, reiterated that there is no shortcut to safe weight loss. She advised that individuals seeking to slim down should always follow medical advice, steer clear of fake medicines, and remember that healthy eating and regular exercise remain the most reliable and safest methods for achieving and maintaining a healthy weight.

Why this matters: This warning is crucial for UK households as it addresses the growing trend of potentially dangerous weight loss practices, protecting consumers from health risks and financial scams. It underscores the importance of legitimate medical advice over misleading online claims.

What this means for you: What this means for you: If you are considering weight loss, especially using medication, it is vital to consult your GP and obtain prescriptions only through legitimate channels. Avoid unregulated online sellers to protect your health and finances from potentially harmful or ineffective products.

Related Articles

Get the news that matters.

Join thousands of readers getting the best of British news straight to their inbox.